Pleural tumors as sole primary manifestation of acute promyelocytic leukemia [4]

Annals of Oncology

Volumn 17, Issue 4, 2006, Pages 722-723

  Mueller, B U ^a   Buerger, A U ^a   Solenthaler, M ^a   Garamvoelgyi, E M ^a   Oppliger Leibundgut, E ^a   Fey, M F ^a   Pabst, Thomas ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; CYTARABINE; DAUNORUBICIN; FLT3 LIGAND; HYDROXYUREA; RETINOIC ACID RECEPTOR ALPHA; TRANSCRIPTION FACTOR RUNX1;

ACUTE GRANULOCYTIC LEUKEMIA; AGED; BLOOD ANALYSIS; BONE MARROW BIOPSY; BONE SCINTISCANNING; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CAUSE OF DEATH; CHROMOSOME 16; CHROMOSOME INVERSION; CHROMOSOME TRANSLOCATION 21; CHROMOSOME TRANSLOCATION 22; CHROMOSOME TRANSLOCATION 8; CHROMOSOME TRANSLOCATION 9; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; LEUKEMIA RELAPSE; LUNG INFECTION; MINIMAL RESIDUAL DISEASE; MUTATIONAL ANALYSIS; PLEURA BIOPSY; PLEURA TUMOR; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA;

EID: 33645297366     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdj062     Document Type: Letter

References (5)

1. Rowley JD, Golomb HM, Dogherty C. 15/17 translocation: A consistent chromosomal change in acute promyelocytic leukemia. Lancet 1977; 1: 549-550.
2. Chou WC, Dang CV. Acute promyelocytic leukemia: Recent advances in therapy and molecular basis of response to arsenic therapies. Curr Opin Hematol 2005; 12: 1-6.
3. Mistry AR, Pedersen EW, Solomon E, Grimwade D. The molecular pathogenesis of acute promyelocytic leukaemia. Implications for the clinical management of the disease. Blood 2003; 17: 71-97.
4. Menendez A, Gonzalez A, Cabrera H et al. Clinical spectrum of extramedullary acute promyelocytic leukemia. Eur J Haematol 2000; 64: 201-203.
5. Wiernik PH, De Bellis R, Muxi P, Dutcher JP. Extramedullary acute promyelocytic leukemia. Cancer 1996; 78: 2510-2514.